Overcoming Treatment Challenges in the Treatment-Experienced Patient With HIV A ... 1. Fundaci n Huesped, Buenos Aires, Argentina; 2. Duke University, Durham, NC, USA ...
Phase II Study of the Safety and Efficacy of ... A5211: Baseline and Disposition. Baseline characteristics: N = 118 subjects ... Disposition (through 48 weeks) ...
1 subject on PBO developed multiple cutaneous squamous cell carcinomas ... response, and 1 month later developed localized perianal squamous cell carcinoma ...
Connects the DNA polymerase (1-315) and RNase H (438-560) domains ... Richard Harrigan. Sheldon Brown. Tassos Kyriakides. Bill Cameron. Brian Angus. Mark Holodniy ...
DUET-1 and -2 differed only in geographical location; pooled analysis was pre-specified ... new AIDS-defining illness or death. ENF = enfuvirtide; BR ...